TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 63 filers reported holding TCR2 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $54,000 | -55.2% | 36,000 | -70.2% | 0.00% | – |
Q4 2022 | $120,532 | -77.0% | 120,677 | -58.6% | 0.00% | -100.0% |
Q3 2022 | $525,000 | -45.1% | 291,568 | -11.6% | 0.00% | -33.3% |
Q2 2022 | $956,000 | -53.2% | 329,657 | -55.4% | 0.00% | -50.0% |
Q1 2022 | $2,042,000 | -42.7% | 739,779 | -3.2% | 0.01% | -25.0% |
Q4 2021 | $3,562,000 | +30.0% | 764,404 | +137.5% | 0.01% | +33.3% |
Q3 2021 | $2,739,000 | -35.4% | 321,859 | +24.5% | 0.01% | -40.0% |
Q2 2021 | $4,241,000 | -35.6% | 258,446 | -13.4% | 0.01% | -41.2% |
Q1 2021 | $6,587,000 | +94.0% | 298,325 | +171.7% | 0.02% | +70.0% |
Q4 2020 | $3,396,000 | +1517.1% | 109,791 | +964.1% | 0.01% | +900.0% |
Q3 2020 | $210,000 | – | 10,318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |